{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:00:12Z","timestamp":1784934012603,"version":"3.55.0"},"reference-count":18,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"abstract":"<jats:p>Methadone maintenance treatment might be commonly associated with lying for several causes or manipulating psychiatrists and therapists by a number of patients. Deceptive patients tend to manipulate their psychiatrists for multiple causes. This study aims to improve clinicians\u2019 therapeutic decision-making by identifying the reasons for increasing daily methadone maintenance dosage among deceptive patients. One hundred ninety-six patients undergoing the Methadone Maintenance Treatment (MMT) with no statistically significant difference between the overall Addiction Severity Index (ASI) scores at different doses of methadone (&lt; 60 mg\/d and \u2265 60 mg\/d) and Ahvaz Reality Distortion Inventory (ARDI) scores &gt; 30, were examined in the current qualitative study with multiple semi-structural interviews about the reasons for increasing daily methadone maintenance dosage. The investigation results revealed that the most common reasons for increasing daily methadone maintenance dosage among deceptive patients were opium craving, patient willingness to feel euphoria, fear of the withdrawal signs, earn money through the sale of surplus methadone, improve the symptoms of physical and psychiatric comorbidity, forgetting painful memories, curiosity, the influence of others, sexual issues, feeling of well-being, and appearance changes. Given these reasons, any increase in daily methadone maintenance dosage is not necessarily accompanied by improvement in the clinical condition of patients. However, clinicians can make the most appropriate therapeutic decision by putting the psychological assessments and clinical interviews into play.<\/jats:p>","DOI":"10.25122\/jml-2020-0038","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T08:35:52Z","timestamp":1668760552000},"page":"572-579","source":"Crossref","is-referenced-by-count":3,"title":["Reasons for Increasing Daily Methadone Maintenance Dosage among Deceptive Patients: A Qualitative Study"],"prefix":"10.25122","volume":"13","author":[{"given":"Mohsen","family":"Khosravi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Psychiatry and Clinical Psychology, Zahedan University of Medical Sciences, Zahedan, Iran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Mohsen Khosravi, Department of Psychiatry and Clinical Psychology, Baharan Psychiatric Hospital, Zahedan University of Medical Sciences, Postal Code: 9813913777, Zahedan, Iran Phone: +98-5433522636 Fax: +98-5433518352 E-mail: m.khosravi@zaums.ac.ir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashya","family":"Kasaeiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Clinical Psychology, Shiraz University of Medical Sciences, Shiraz, Iran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10755","published-online":{"date-parts":[[2020,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"1. Brown R, Kraus C, Fleming M, Reddy S. Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgraduate medical journal. 2004;80(949):654-9.","DOI":"10.1136\/pgmj.2004.022988"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"2. Chou R, Cruciani RA, Fiellin DA, Compton P, Farrar JT, Haigney MC, et al. Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society. The Journal of Pain. 2014;15(4):321-37.","DOI":"10.1016\/j.jpain.2014.01.494"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"3. Cruz M, Roter DL, Cruz RF, Wieland M, Larson S, Cooper LA, et al. Appointment length, psychiatrists\u2019 communication behaviors, and medication management appointment adherence. Psychiatric Services. 2013;64(9):886-92.","DOI":"10.1176\/appi.ps.201200416"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. Darke S, Sims J, McDonald S, Wickes W. Cognitive impairment among methadone maintenance patients. Addiction. 2000;95(5):687-95.","DOI":"10.1046\/j.1360-0443.2000.9556874.x"},{"key":"ref5","unstructured":"5. Edwards G, Arif A, Hadgson R. Nomenclature and classification of drug-and alcohol-related problems: a WHO Memorandum. Bulletin of the World Health Organization. 1981;59(2):225-42."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Gutwinski S, Schoofs N, Stuke H, Riemer TG, Wiers CE, Bermpohl F. Opioid tolerance in methadone maintenance treatment: comparison of methadone and levomethadone in long-term treatment. Harm reduction journal. 2016;13(1):7.","DOI":"10.1186\/s12954-016-0095-0"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"7. Hall SM, Loeb PC, Kushner M. Methadone dose decreases and anxiety reduction. Addictive behaviors. 1984;9(1):11-9.","DOI":"10.1016\/0306-4603(84)90003-0"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. Kao DP, Haigney MC, Mehler PS, Krantz MJ. Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration. Addiction. 2015;110(9):1468-75.","DOI":"10.1111\/add.13013"},{"key":"ref9","unstructured":"9. Mack AH, Brady KT, Frances RJ, Miller SI. Clinical textbook of addictive disorders: Guilford Publications; 2016."},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Martin WR, Hewett BB, Baker AJ, Haertzen CA. Aspects of the psychopathology and pathophysiology of addiction. Drug and Alcohol Dependence. 1977;2(3):185-202.","DOI":"10.1016\/0376-8716(77)90026-6"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The fifth edition of the Addiction Severity Index. Journal of substance abuse treatment. 1992;9(3):199-213.","DOI":"10.1016\/0740-5472(92)90062-S"},{"key":"ref12","unstructured":"12. Najarian B, Sudani M. Making and Validating a Scale for Measuring Reality Distortion. Journal of Educational Sciences and Psychology. 2001;2(1):99-114."},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. Racker H. Transference and countertransference: Routledge; 2018.","DOI":"10.4324\/9780429484209"},{"key":"ref14","unstructured":"14. Rogers R, Bender SD. Clinical assessment of malingering and deception: Guilford Press; 2020."},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"15. Rogers WA. Is there a moral duty for doctors to trust patients? Journal of Medical Ethics. 2002;28(2):77-80.","DOI":"10.1136\/jme.28.2.77"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. Roux P, Lions C, Michel L, Cohen J, Mora M, Marcellin F, et al. Predictors of non-adherence to methadone maintenance treatment in opioiddependent individuals: Implications for clinicians. Current pharmaceutical design. 2014;20(25):4097-105.","DOI":"10.2174\/13816128113199990623"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"17. Trujols J, Gonz\u00e1lez-Saiz F, Manresa MJ, Alcaraz S, Batlle F, Duran- Sindreu S, et al. Patient perception of methadone dose adequacy in methadone maintenance treatment: The role of perceived participation in dosage decisions. Patient education and counseling. 2017;100(5):981-6.","DOI":"10.1016\/j.pec.2016.12.001"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"18. Trujols J, Si\u00f1ol N, de los Cobos JP. Methadone maintenance treatment: the need to distinguish between holding dose, dose adequacy, satisfaction with methadone as a medication, and satisfaction with treatment. Journal of clinical psychopharmacology. 2010;30(1):95-6.","DOI":"10.1097\/JCP.0b013e3181c8b439"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/JMedLife-13-572.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T08:36:10Z","timestamp":1668760570000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/JMedLife-13-572.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["JMedLife-13-572"],"URL":"https:\/\/doi.org\/10.25122\/jml-2020-0038","relation":{},"ISSN":["1844-122X","1844-3117"],"issn-type":[{"value":"1844-122X","type":"print"},{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}